Publication Cover
Orbit
The International Journal on Orbital Disorders, Oculoplastic and Lacrimal Surgery
Volume 36, 2017 - Issue 6
297
Views
8
CrossRef citations to date
0
Altmetric
Research Article

The impact of IgG-4-ROD on the diagnosis of orbital tumors: A retrospective analysis

, , , , &
Pages 359-364 | Received 05 Oct 2016, Accepted 28 May 2017, Published online: 22 Aug 2017

References

  • Carruthers MN, Stone JH, Khosroshahi A. The latest on IgG4-RD: A rapidly emerging disease. Curr Opin Rheumatol 2012; 24: 60–69.
  • Cheuk W, Chan JK. IgG4-related sclerosing disease: A critical appraisal of an evolving clinicopathologic entity. Adv Anat Pathol 2010; 17:303–332.
  • Divatia M, Kim SA, Ro JY. IgG4-related sclerosing disease, an emerging entity: a review of a multi-system disease. Yonsei Med J 2012; 53:15–34.
  • Stone JH, Zen Y & Deshpande V. IgG4-related disease. N Engl J Med 2012; 366:539–551.
  • Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD). Mod Rheumatol. 2011; 22:21–30.
  • Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol 2012; 25:1181–1192.
  • Masaki Y, Kurose N, Yamamoto M, et al. Cutoff values of serum IgG4 and histopathological IgG4+ plasma cells for diagnosis of patients with IgG4-related disease. Int J Rheumatol 2012; 580–814.
  • Nirula A, Glaser SM, Kalled SL, Taylor FR. What is IgG4? A review of the biology of a unique immunoglobulin subtype. Curr Opin Rheumatol 2012; 23: 119–124.
  • Lighaam LC, Aalberse RC & Rispens T. IgG4-related fibrotic diseases from an immunological perspective: Regulators out of control? Int J Rheumatol 2012; 2012: article 789164.
  • Kanari H, Kagami S, Kashiwakuma D, et al. Role of Th2 cells in IgG4-related lacrimal gland enlargement. Int Arch Allergy Immunol 2010; 152(Suppl 1):47–53.
  • Kubota T, Moritani S, Katayama M & Terasaki H. Ocular adnexal IgG4-related lymphoplasmacytic infiltrative disorder. Arch Ophthalmol 2010; 128: 577–584.
  • Go H, Kim JE, Kim YA, et al. Ocular adnexal IgG4-related disease: Comparative analysis with mucosa-associated lymphoid tissue lymphoma and other chronic inflammatory conditions. Histopathology 2012; 60: 296–312.
  • Matsuo T, Ichimura K, Sato Y. Immunoglobulin G4 (IgG4)-positive or -negative ocular adnexal benign lymphoid lesions in relation to systemic involvement. J Clin Exp Hematol 2010; 50:129–142.
  • Lindfield D, Attfield K, McElvanney A. Systemic immunoglobulin G4 (IgG4) disease and idiopathic orbital inflammation; Removing ‘idiopathic’ from the nomenclature? Eye (Lond) 2012; 26:623–629.
  • Mehta M, Jakobiec F, Fay A. Idiopathic fibroinflammatory disease of the face, eyelids, and periorbital membrane with immunoglobulin G4-positive plasma cells. Arch Pathol Lab Med 2009; 133:1251–1255.
  • Plaza JA, Garrity JA, Dogan A, Ananthamurthy A, Witzig TE, Salomao DR. Orbital inflammation with IgG4-positive plasma cells: Manifestation of IgG4 systemic disease. Arch Ophthalmol 2011; 129:421–428.
  • Wallace ZS, Khosroshahi A, Jakobiec FA, et al. IgG4-related systemic disease as a cause of “idiopathic” orbital inflammation, including orbital myositis, and trigeminal nerve involvement. Surv Ophthalmol 2012; 57:26–33.
  • Andrew N, Kearney D, Selva D. IgG4-related orbital disease: A meta-analysis and review. Acta Ophthalmol 2013; 91(8):694–700.
  • Sato Y, Ohshima K, Ichimura K, et al. Ocular adnexal IgG4-related disease has uniform clinicopathology. Pathol Int 2008; 58:465–470.
  • Karamchandani JR, Younes SF, Warnke RA, Natkunam Y. IgG4-related systemic sclerosing disease of the ocular adnexa: A potential mimic of ocular lymphoma. Am J Clin Pathol 2012; 137:699–711.
  • Ferry JA, et al. IgG-4 related orbital disease and its mimics in a Western population. Am J Surg Pathol 2015; 39(12):1688–1700.
  • Deschamps R, Deschamps L, Depaz R et al. High prevalence of IgG-4 related lymphocytoplasmic infiltrative disorder in 25 patients with orbital inflammation: retrospective case series. Br J Ophthalmol 2013; 97:999–1004.
  • Wu A, Andrew N, Mcnab A, et al. IgG4-related ophthalmic disease: Pooling of published cases of literature and review. Curr Allergy Asthma Rep 2015;15:27.
  • Sogabe Y,Ohshima K, Azumi A, et al. Location and frequency of lesions in patients with IgG-4-related ophthalmic diseases. Graefes Arch Clin Exp Ophthalmol 2014; 252:531–538.
  • Kubota T, Moritani S. Orbital IgG4-related disease: Clinical features and diagnosis. ISRN Rheumatol 2012; 2012:412896.
  • Lindfield D, Attfield K, McElvanney A. Systematic immunoglobulin g4 (IgG4) disease and ‘idiopathic’ orbital inflammation; removing idiopathic from the nomenclature? Eye (Lond) 2012; 26(5):623–629.
  • Chaudry IA, Shamsi FA, Arat YO, Riley FC Orbital pseudotumor: Distinct diagnostic features and management. Middle East Afr L Ophthalmol 2008; 15(1):17–27.
  • Kase S, Noda M, Ishijima K, Yamamoto T, Hatanaka K, Ishida S. IgG4-related inflammation of the orbit simulating malignant lymphoma. Anticancer Res 2013; 33(6):2779–2783.
  • Shields JA, Shields CL, Scartozzi R. Survey of 1,264 patients with orbital tumors and simulating lesions: The 2002 Montgomery Lecture, part 1. Ophthalmology 2004; 111(5):997–1008.
  • Mcnab A, McKelvie P. IgG-4 related ophthalmic disease. Part II: Clinical aspects. Ophthal Plas Reconstr Surg 2015; 31:167–178.
  • Geyer JT, Deshpande V. IgG-4-associated sialadenitis. Curr Opin Rheumatol 2011; 23:95–101.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.